Infectious Disease Diagnostics Market to Grow by USD 13.94 Bn, 37% of Market Growth to Originate from North America - Technavio

NEW YORK, Nov. 2, 2022 /PRNewswire/ -- The infectious disease diagnostics market size is expected to grow by USD 13.94 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 6.7% during the forecast period. The market has been segmented by end-user (hospitals and labs) and geography (North America, Europe, Asia, and Rest of the World (ROW)).

Find a comprehensive report summary that describes the market size and forecast along with the research methodology. The FREE sample report is available in PDF format

Infectious Disease Diagnostics Market: Segmentation Analysis

By geography, North America will lead the thermostatic radiator valve market during the forecast period. The region will account for 37% of the market's growth. The increase in the prevalence of infectious diseases, such as AIDS, TB, meningitis, influenza, and pneumonia will facilitate the infectious disease diagnostics market growth in North America over the forecast period.

Get lifetime access to our Technavio Insights! Subscribe to our "Basic Plan" billed annually at USD 5000

By end-user, the hospital segment will be the largest contributor to market growth during the forecast period. The growth is attributed to the increase in the number of patients suffering from different types of diseases, such as AIDS, tuberculosis (TB) meningitis, and COVID-19, globally. The growing presence of the large-, medium-, and small-sized hospitals that procure medical products, including infectious disease diagnostic instruments, in bulk from suppliers and group purchasing organizations (GPOs) will further boost the market growth. 

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. Buy Now to gain access to detailed information about each segment

Infectious Disease Diagnostics Market: Driver and Trend

One of the key factors driving the global infectious disease diagnostics market growth is the increasing prevalence of infectious diseases. The outbreaks of infectious diseases have increased due to changing lifestyles, which result in reduced immunity. The pattern of infection incidence has also been changing with the evolution of drug-resistant pathogens. As per the Joint United Nations Programme on HIV/AIDS data of 2020, 680,000 people died from AIDS-related illnesses across the world. The rise in the prevalence of infectious diseases is expected to drive the growth of the market in focus during the forecast period.

An increase in M&A is one of the key infectious disease diagnostics market trends that is expected to impact the industry positively in the forecast period. The vendors operating in the market are focusing on pursuing inorganic growth to tap into rapidly growing markets, such as India, Brazil, China, and South Africa. In August 2021, Sanofi S.A acquired Translate Bio Inc., a clinical-stage mRNA therapeutics company, for over $3 billion. A rise in M&A activities across the globe is anticipated to boost the growth of the market in the forecast years.

Identify key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report

Related Reports:

In-vitro Diagnostics Market by Technology and Geography – Forecast and Analysis 2022-2026: The in-vitro diagnostics market is projected to grow by USD 33.16 billion during the forecast period 2021 to 2026.

Heart Attack Diagnostics Market by End-user and Geography – Forecast and Analysis 2022-2026: The heart attack diagnostics market share is expected to increase by USD 5.34 billion from 2021 to 2026.

Table of Contents:

1 Executive Summary

• 1.1 Market Overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market Definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

• 5.1 Market segments
• Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
• Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)

• 5.2 Comparison by End-user 
• Exhibit 26: Chart on Comparison by End-user
• Exhibit 27: Data Table on Comparison by End-user

• 5.3 Hospitals - Market size and forecast 2021-2026 
• Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)

• 5.4 Labs - Market size and forecast 2021-2026 
• Exhibit 32: Chart on Labs - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Labs - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Labs - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Labs - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by End-user 
• Exhibit 36: Market opportunity by End-user ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026 
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026 
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026 
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026 
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026 
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026 
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 China - Market size and forecast 2021-2026 
• Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.10 UK - Market size and forecast 2021-2026 
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.11 Canada - Market size and forecast 2021-2026 
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 84: Matrix on vendor position and classification

• 10.3 Abbott Laboratories
• Exhibit 85: Abbott Laboratories - Overview
• Exhibit 86: Abbott Laboratories - Business segments
• Exhibit 87: Abbott Laboratories - Key news
• Exhibit 88: Abbott Laboratories - Key offerings
• Exhibit 89: Abbott Laboratories - Segment focus

• 10.4 Becton Dickinson and Co. 
• Exhibit 90: Becton Dickinson and Co. - Overview
• Exhibit 91: Becton Dickinson and Co. - Business segments
• Exhibit 92: Becton Dickinson and Co. - Key news
• Exhibit 93: Becton Dickinson and Co. - Key offerings
• Exhibit 94: Becton Dickinson and Co. - Segment focus

• 10.5 Bio Rad Laboratories Inc. 
• Exhibit 95: Bio Rad Laboratories Inc. - Overview
• Exhibit 96: Bio Rad Laboratories Inc. - Business segments
• Exhibit 97: Bio Rad Laboratories Inc. - Key news
• Exhibit 98: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 99: Bio Rad Laboratories Inc. - Segment focus

• 10.6 bioMerieux SA
• Exhibit 100: bioMerieux SA - Overview
• Exhibit 101: bioMerieux SA - Product / Service
• Exhibit 102: bioMerieux SA - Key offerings

• 10.7 DiaSorin SpA
• Exhibit 103: DiaSorin SpA - Overview
• Exhibit 104: DiaSorin SpA - Business segments
• Exhibit 105: DiaSorin SpA - Key offerings
• Exhibit 106: DiaSorin SpA - Segment focus

• 10.8 F. Hoffmann La Roche Ltd. 
• Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus

• 10.9 Hologic Inc.
• Exhibit 112: Hologic Inc. - Overview
• Exhibit 113: Hologic Inc. - Business segments
• Exhibit 114: Hologic Inc. - Key news
• Exhibit 115: Hologic Inc. - Key offerings
• Exhibit 116: Hologic Inc. - Segment focus

• 10.10 QIAGEN NV
• Exhibit 117: QIAGEN NV - Overview
• Exhibit 118: QIAGEN NV - Product / Service
• Exhibit 119: QIAGEN NV - Key news
• Exhibit 120: QIAGEN NV - Key offerings

• 10.11 Thermo Fisher Scientific Inc. 
• Exhibit 121: Thermo Fisher Scientific Inc. - Overview
• Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 123: Thermo Fisher Scientific Inc. - Key news
• Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus

• 10.12 Trinity Biotech Plc
• Exhibit 126: Trinity Biotech Plc - Overview
• Exhibit 127: Trinity Biotech Plc - Product / Service
• Exhibit 128: Trinity Biotech Plc - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 129: Inclusions checklist
• Exhibit 130: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 131: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 132: Research methodology
• Exhibit 133: Validation techniques employed for market sizing
• Exhibit 134: Information sources

• 11.5 List of abbreviations 
• Exhibit 135: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio